ERBB2, a receptor tyrosine kinase, is overexpressed in a subset of pancreatic cancers and a predictive tool for survival in patients with pancreatic cancer in histological studies (Ortega et al. 2022). The gene discussed is NTRK1; the disease is pancreatic neoplasm.